such guidelines, the pharmaceutical industry appears to be an important candidate for antitrust attention, given the …

governments should bear the cost of the expected increased industry obsolescence determined by a temporary patent waiver; this … includes public patent-buy-outs and regulated public-private R&D partnerships. …

) provides for global minimum standard patents. These patents potentially limit access to the products and processes for the … patents might be mediated including through TRIPS flexibilities. The comment argues that there are sufficient means of … derogating from patents (and potentially copyright, industrial designs and undisclosed information), although that alone will not …